IMPROVED OUTCOMES IN PATIENTS (PTS) WITH BCL2‐POSITIVE DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL) TREATED WITH VENETOCLAX (VEN) PLUS R‐CHOP: RESULTS FROM THE PHASE 2 CAVALLI STUDY | Zendy

Morschhauser F. | Zendy; Flinn I.W. | Zendy; Gasiorowski R. | Zendy; Illés Á. | Zendy; Feugier P. | Zendy; Greil R. | Zendy; Johnson N.A. | Zendy; Larouche J. | Zendy; Lugtenburg P.J. | Zendy; Patti C. | Zendy; Salles G. | Zendy; Trněný M. | Zendy; Vos S. | Zendy; Mir F. | Zendy; Kornacker M. | Zendy; Punnoose E.A. | Zendy; Samineni D. | Zendy; SzaferGlusman E. | Zendy; Petrich A. | Zendy; Sinha A. | Zendy; Spielewoy N. | Zendy; Humphrey K. | Zendy; Bazeos A. | Zendy; Zelenetz A.D. | Zendy

Premium

IMPROVED OUTCOMES IN PATIENTS (PTS) WITH BCL2‐POSITIVE DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL) TREATED WITH VENETOCLAX (VEN) PLUS R‐CHOP: RESULTS FROM THE PHASE 2 CAVALLI STUDY

Author(s) -

Morschhauser F.,

Flinn I.W.,

Gasiorowski R.,

Illés Á.,

Feugier P.,

Greil R.,

Johnson N.A.,

Larouche J.,

Lugtenburg P.J.,

Patti C.,

Salles G.,

Trněný M.,

Vos S.,

Mir F.,

Kornacker M.,

Punnoose E.A.,

Samineni D.,

SzaferGlusman E.,

Petrich A.,

Sinha A.,

Spielewoy N.,

Humphrey K.,

Bazeos A.,

Zelenetz A.D.

Publication year - 2019

Publication title -

hematological oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.918

H-Index - 44

eISSN - 1099-1069

pISSN - 0278-0232

DOI - 10.1002/hon.95_2629

Subject(s) - medicine , clinical endpoint , diffuse large b cell lymphoma , chop , rituximab , ven , oncology , gastroenterology , venetoclax , regimen , lymphoma , randomized controlled trial , chronic lymphocytic leukemia , leukemia , computer security , computer science

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research